Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bacigalupo

Showing results (1-10 of 458) with videos related to

Pageof 46
Sort By:
Leukemia|September 13, 2003
Response to imatinib in patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemiaA Bacigalupo
Bone Marrow Transplantation|February 23, 2002
Second EBMT Workshop on reduced intensity allogeneic hemopoietic stem cell transplants (RI-HSCT)A Bacigalupo
Bone Marrow Transplantation|September 25, 2008
Treatment strategies for patients with severe aplastic anemiaA Bacigalupo
Bone Marrow Transplantation|November 24, 2004
Antilymphocyte/thymocyte globulin for graft versus host disease prophylaxis: efficacy and side effectsA Bacigalupo
Haematologica|March 26, 1999
Bone marrow transplantation for severe aplastic anemia from HLA identical siblingsA Bacigalupo
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
The clinical benefits of recombinant human granulocyte colony stimulating factor in the treatment of cancer patientsA Bacigalupo
Haematologica|September 1, 1994
Guidelines for the treatment of severe aplastic anemia. Working Party on Severe Aplastic Anemia (WPSAA) of the European Group of Bone Marrow Transplantation (EBMT)A Bacigalupo
European Journal of Haematology. Supplementum|January 1, 1996
Aetiology of severe aplastic anaemia and outcome after allogeneic bone marrow transplantation or immunosuppression therapy. Working Party on Severe Aplastic Anaemia of the European Blood and Marrow Transplantation GroupA Bacigalupo
Bone Marrow Transplantation|May 16, 2000
Hematopoietic stem cell transplants after reduced intensity conditioning regimen (RI-HSCT): report of a workshop of the European group for Blood and Marrow Transplantation (EBMT)A Bacigalupo
Bone Marrow Transplantation|February 3, 2004
Third EBMT/AMGEN Workshop on reduced-intensity conditioning allogeneic haemopoietic stem cell transplants (RIC-HSCT), and panel consensusA Bacigalupo
Pageof 46

Showing results (1-10 of 458) with videos related to

Sort By:
Pageof 46
Leukemia|September 13, 2003
Response to imatinib in patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemiaA Bacigalupo
Bone Marrow Transplantation|February 23, 2002
Second EBMT Workshop on reduced intensity allogeneic hemopoietic stem cell transplants (RI-HSCT)A Bacigalupo
Bone Marrow Transplantation|September 25, 2008
Treatment strategies for patients with severe aplastic anemiaA Bacigalupo
Bone Marrow Transplantation|November 24, 2004
Antilymphocyte/thymocyte globulin for graft versus host disease prophylaxis: efficacy and side effectsA Bacigalupo
Haematologica|March 26, 1999
Bone marrow transplantation for severe aplastic anemia from HLA identical siblingsA Bacigalupo
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
The clinical benefits of recombinant human granulocyte colony stimulating factor in the treatment of cancer patientsA Bacigalupo
Haematologica|September 1, 1994
Guidelines for the treatment of severe aplastic anemia. Working Party on Severe Aplastic Anemia (WPSAA) of the European Group of Bone Marrow Transplantation (EBMT)A Bacigalupo
European Journal of Haematology. Supplementum|January 1, 1996
Aetiology of severe aplastic anaemia and outcome after allogeneic bone marrow transplantation or immunosuppression therapy. Working Party on Severe Aplastic Anaemia of the European Blood and Marrow Transplantation GroupA Bacigalupo
Bone Marrow Transplantation|May 16, 2000
Hematopoietic stem cell transplants after reduced intensity conditioning regimen (RI-HSCT): report of a workshop of the European group for Blood and Marrow Transplantation (EBMT)A Bacigalupo
Bone Marrow Transplantation|February 3, 2004
Third EBMT/AMGEN Workshop on reduced-intensity conditioning allogeneic haemopoietic stem cell transplants (RIC-HSCT), and panel consensusA Bacigalupo
Pageof 46